Efficacy and safety study of GSK1358820 in Japanese patients with urinary incontinence due to neurogenic detrusor overactivity

Trial Identifier: 204948
Sponsor: GlaxoSmithKline
Start Date: October 2016
Primary Completion Date: March 2018
Condition: Bladder Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Japan Aomori, Japan, 036-8563
Japan Fukuoka, Japan, 820-8508
Japan Hokkaido, Japan, 060-8648
Japan Hyogo, Japan, 651-2181
Japan Miyagi, Japan, 981-8563
Japan Nagasaki, Japan, 852-8501
Japan Okayama, Japan, 700-8558
Japan Tochigi, Japan, 321-0293
Japan Yamanashi, Japan, 409-3898